Upadacitinib

AbbVie Reports Successful Trial Results for Arthritis Drug
Motley Fool
Wed, 02/5/20 - 10:00 pm
AbbVie
Rinvoq
Upadacitinib
psoriasis
clinical trials
Rinvoq approval bolsters AbbVie's autoimmune portfolio
BioCentury
Fri, 08/16/19 - 11:54 pm
AbbVie
FDA
Rinvoq
Upadacitinib
rheumatoid arthritis
Four New Drugs are Around the Corner. Here’s What You Need to Know.
Xconomy
Thu, 08/15/19 - 11:39 pm
FDA
drug approvals
AbbVie
Upadacitinib
Exondys 51
Sarepta Therapeutics
Nabriva Therapeutics
lefamulin
Roche
Rozlytrek
Watch out AbbVie: Gilead is fast on your heels at the FDA with rival JAK inhibitor filgotinib
Endpoints
Tue, 07/2/19 - 10:46 am
Gilead Sciences
AbbVie
FDA
JAK inhibitors
filgotinib
Upadacitinib
rheumatoid arthritis
3 Drugs Under FDA Review With Blockbuster Potential
Motley Fool
Fri, 06/21/19 - 11:24 am
AbbVie
Upadacitinib
rheumatoid arthritis
Novartis
brolucizumab
wet age-related macular degeneration
Celgene
ozanimod
relapsing multiple sclerosis
Top 5 New Drug Launches of 2019 -- and the Biotech Stocks That Could Win Big
Motley Fool
Sun, 05/19/19 - 04:05 pm
Alexion
Ultomiris
AbbVie
Upadacitinib
risankizumab
Aimmune Therapeutics
AR-101
Bluebird Bio
LentiGlobin
4 Blockbuster Drug Launches to Watch in 2019
Motley Fool
Sun, 03/24/19 - 08:08 pm
drug launches
AbbVie
Alexion Pharmaceuticals
Aimmune Therapeutics
Skyrizi
psoriasis
Upadacitinib
rheumatoid arthritis
Ultomiris
PNH
AR101
peanut allergy
Forget Humira -- Here's What You Need to Know About AbbVie
Motley Fool
Sun, 01/27/19 - 12:13 pm
AbbVie
Humira
Upadacitinib
risankizumab
Rick Gonzalez
AbbVie rheumatoid arthritis drug succeeds in late stage trial
Yahoo/Reuters
Tue, 10/23/18 - 10:40 am
AbbVie
clinical trials
rheumatoid arthritis
Upadacitinib
A Brawl Is Brewing Between AbbVie and Gilead Sciences in Arthritis
Yahoo/Motley Fool
Fri, 09/14/18 - 09:36 am
AbbVie
Gilead Sciences
FDA
rheumatoid arthritis
Upadacitinib
filgotinib
3 Reasons to Expect Smooth Sailing for AbbVie's Mission-Critical Candidate
Yahoo/Motley Fool
Sun, 06/10/18 - 10:59 am
AbbVie
Huimra
Upadacitinib
rheumatoid arthritis
AbbVie to submit upadacitinib to FDA after 5th trial win
Fierce Pharma
Wed, 06/6/18 - 11:31 am
AbbVie
Upadacitinib
rheumatoid arthritis
FDA
JAK inhibitors
Up-and-coming Pfizer, AbbVie drugs set to threaten Amgen, Celgene: analyst
Fierce Pharma
Wed, 05/23/18 - 09:54 am
Pfizer
Xeljanz
AbbVie
Upadacitinib
JAK inhibitors
Amgen
Enbrel
Celgene
AbbVie's Upadacitinib Meets Primary and Key Efficacy Endpoints in Phase 2b/3 Rheumatoid Arthritis Study
CP Wire
Wed, 04/25/18 - 11:16 am
AbbVie
rheumatoid arthritis
Upadacitinib
clinical trials
With study success, AbbVie's arthritis hopeful looks to be a safer bet
Biopharma Dive
Wed, 04/11/18 - 09:18 am
AbbVie
rheumatoid arthritis
Upadacitinib
Humira
clinical trials
AbbVie Presents New Data on Upadacitinib for Crohn's Disease
Yahoo/Zacks.com
Mon, 02/19/18 - 04:18 pm
AbbVie
Upadacitinib
Crohn's Disease
These 3 Drugs Are Critical to AbbVie's Success
Motley Fool
Mon, 02/12/18 - 09:10 am
AbbVie
Rova-T
Upadacitinib
risankizumab
ABBV to Focus on Advancing Late-Stage Immunology Research in 2018
Market Realist
Thu, 02/8/18 - 11:17 am
AbbVie
R&D
immunology
Upadacitinib
risankizumab
Why AbbVie's Upadacitinib Keeps Posting Strong Data for Rheumatoid Arthritis
Market Realist
Mon, 01/8/18 - 09:42 am
AbbVie
Upadacitinib
rheumatoid arthritis
Another death mars AbbVie’s latest batch of promising data for its star rheumatoid arthritis drug
BioPharma Dive
Wed, 12/20/17 - 11:42 am
AbbVie
rheumatoid arthritis
Upadacitinib
ABT-494

Pages